Literature DB >> 9658202

Structural determinants of potency and stereoselective block of hKv1.5 channels induced by local anesthetics.

M Longobardo1, E Delpón, R Caballero, J Tamargo, C Valenzuela.   

Abstract

Block of hKv1.5 channels by bupivacaine is stereoselective, with (R)-(+)-bupivacaine being 7-fold more potent than (S)-(-)-bupivacaine. The study of the effects of chemically related enantiomers on these channels may help to elucidate the structural determinants of stereoselective hKv1.5 channels block by local anesthetics. In this study, we analyzed the effects of (R)-(+)-ropivacaine, (R)-(+)-mepivacaine, and (S)-(-)-mepivacaine on hKv1.5 channels stably expressed in Ltk- cells. (R)-(+)-Ropivacaine inhibited hKv1.5 current and induced a fast initial decline superimposed to the slow inactivation during the application of depolarizing pulses, which reached steady state at the end of 250-msec depolarizing pulses. The concentration-dependence block induced by (R)-(+)-ropivacaine yielded a KD value of 32 +/- 1 microM [i.e., 2.5-fold more potent than (S)-(-)-ropivacaine]. (R)-(+)-Ropivacaine block also was voltage dependent, with a fractional electrical distance (delta) of 0.156 +/- 0.003 (n = 14) referred to the inner surface. Both (S)-(-)- and (R)-(+)-mepivacaine blocked hKv1.5 channels, with KD values of 286.8 +/- 34.1 and 379.0 +/- 56.0 microM, respectively [i.e., block was not stereoselective (p > 0.05)]. (S)-(-)-Mepivacaine and (R)-(+)-mepivacaine block displayed no apparent time-dependence due to a very fast dissociation rate constant. However, block by mepivacaine enantiomers was voltage dependent, with delta values of 0.154 +/- 0.015 and 0.160 +/- 0.008 for the (S)-(-)- and (R)-(+)-enantiomers, respectively. We conclude that (1) (R)-(+)-ropivacaine and mepivacaine enantiomers block the open state of hKv1.5 channels and (2) the length of their alkyl substituent at position 1 determines the potency and the degree of stereoselectivity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9658202     DOI: 10.1124/mol.54.1.162

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: stereoselective bupivacaine block.

Authors:  Teresa González; Cristina Arias; Ricardo Caballero; Ignacio Moreno; Eva Delpón; Juan Tamargo; Carmen Valenzuela
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Modeling the effect of Kv1.5 block on the canine action potential.

Authors:  Joachim Almquist; Mikael Wallman; Ingemar Jacobson; Mats Jirstrand
Journal:  Biophys J       Date:  2010-11-03       Impact factor: 4.033

3.  Stereoselective effects of the enantiomers of a new local anaesthetic, IQB-9302, on a human cardiac potassium channel (Kv1.5).

Authors:  T González; M Longobardo; R Caballero; E Delpón; J V Sinisterra; J Tamargo; C Valenzuela
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

4.  Effects of a quaternary bupivacaine derivative on delayed rectifier K(+) currents.

Authors:  M Longobardo; T González; R Navarro-Polanco; R Caballero; E Delpón; J Tamargo; D J Snyders; M M Tamkun; C Valenzuela
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

5.  Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac kv1.5 channels.

Authors:  R Caballero; C Valenzuela; M Longobardo; J Tamargo; E Delpón
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

6.  The inhibitory effects of bupivacaine, levobupivacaine, and ropivacaine on K2P (two-pore domain potassium) channel TREK-1.

Authors:  Hye Won Shin; Jeong Seop Soh; Hee Zoo Kim; Jinpyo Hong; Dong Ho Woo; Jun Young Heo; Eun Mi Hwang; Jae-Yong Park; C Justin Lee
Journal:  J Anesth       Date:  2014-02       Impact factor: 2.078

7.  Selective open-channel block of Shaker (Kv1) potassium channels by s-nitrosodithiothreitol (SNDTT).

Authors:  M W Brock; C Mathes; W F Gilly
Journal:  J Gen Physiol       Date:  2001-07       Impact factor: 4.086

8.  PKC inhibition results in a Kv 1.5 + Kv β1.3 pharmacology closer to Kv 1.5 channels.

Authors:  A Macías; A de la Cruz; A Prieto; D A Peraza; M M Tamkun; T González; C Valenzuela
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

9.  Modulation of KV4.3-KChIP2 Channels by IQM-266: Role of DPP6 and KCNE2.

Authors:  Angela de Benito-Bueno; Paula G Socuellamos; Yaiza G Merinero; Pilar Cercos; Carolina Izquierdo; Miguel Daniel-Mozo; Irene Marín-Olivero; Angel Perez-Lara; Juan A Gonzalez-Vera; Angel Orte; Armando Albert; Mercedes Martin-Martinez; Marta Gutierrez-Rodriguez; Carmen Valenzuela
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.